Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2016-06-17 Capital/Financing Update
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
FORM S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used for registering securities for public offering. It includes detailed information about the securities to be offered, the registration fee calculation, and legal disclaimers. This type of filing is related to capital raising activities and financing. It is not an annual report, earnings release, or any other financial report but specifically a registration statement for securities offerings under the Securities Act of 1933. Therefore, it fits the category of Capital/Financing Update filings.
2016-06-17 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about the Annual Meeting of Stockholders, voting results on director elections, approval of amendments to the stock incentive plan, and ratification of the independent auditor. It also includes Item 5.02 about departure and election of directors and Item 5.07 about submission of matters to a vote of security holders. The document is not a full annual report or financial statement but rather a report of corporate governance events and voting results. The presence of detailed voting results and director elections aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 7406 characters, which is sufficient to include substantive voting results rather than just an announcement of a report. Therefore, the best classification is DVA with high confidence.
2016-05-27 English
FORM 4 SUBMISSION
Director's Dealing
2016-05-26 English
FORM 4 SUBMISSION
Director's Dealing
2016-05-26 English
FORM 4 SUBMISSION
Director's Dealing
2016-05-26 English
FORM 4 SUBMISSION
Director's Dealing
2016-05-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.